Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | CACNA1D | Q01668 | 6/20 | 0.35 |
| ▸ | CACNA1F | O60840 | 5/20 | 0.35 |
| ▸ | CACNA1S | Q13698 | 5/20 | 0.35 |
| ▸ | CACNA1C | Q13936 | 5/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | BCL9 | O00512 | 1/20 | 0.34 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6197215 | 1.00 | ADRA1A (0.36) | ADRA1ACACNA1DCACNA1FCACNA1SCACNA1C | |
| SCHEMBL8596050 | 0.89 | ADRA1A (0.31) | ADRA1ABCL9CTNNB1KMT2A | |
| SCHEMBL6782160 | 0.86 | ADRA1A (0.36) | ADRA1ACACNA1DCACNA1FCACNA1SCACNA1C | |
| SCHEMBL6786377 | 0.84 | — | — | |
| SCHEMBL6217186 | 0.82 | ADRA1A (0.37) | ADRA1ACACNA1DCACNA1FCACNA1SCACNA1C | |
| SCHEMBL6646229 | 0.79 | ADRA1D (0.39) | ADRA1ACACNA1DCACNA1FCACNA1SCACNA1C | |
| SCHEMBL6216267 | 0.78 | PDE1C (0.38) | CACNA1DCACNA1FCACNA1SCACNA1CMGLL | |
| SCHEMBL6715281 | 0.77 | BCL9 (0.35) | ADRA1ACACNA1DCACNA1FCACNA1SCACNA1C | |
| SCHEMBL6715274 | 0.77 | BCL9 (0.35) | ADRA1ACACNA1DCACNA1FCACNA1SCACNA1C | |
| SCHEMBL6782795 | 0.77 | ADRA1A (0.36) | ADRA1ACACNA1DCACNA1CADORA3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5942517-A | ANTAGONIST OF ALPHA(1C) RECEPTORS; TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 1999-08-24 | — | — | US | disclosed |